A Preference Study Comparing Kristalose® and Liquid Lactulose
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00712543|
Recruitment Status : Completed
First Posted : July 10, 2008
Results First Posted : September 27, 2011
Last Update Posted : September 27, 2011
|Condition or disease||Intervention/treatment||Phase|
|Constipation||Drug: lactulose (Kristalose®) Drug: liquid lactulose||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||50 participants|
|Intervention Model:||Crossover Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Preference Study Comparing Kristalose® and Liquid Lactulose in the Treatment of Constipation|
|Study Start Date :||June 2009|
|Actual Primary Completion Date :||September 2009|
|Actual Study Completion Date :||September 2009|
Kristalose®, as prescribed, for 7 days.
Drug: lactulose (Kristalose®)
Crystals to be dissolved in water and taken as prescribed.
Other Name: Kristalose®
Liquid lactulose, as prescribed, for 7 days.
Drug: liquid lactulose
Liquid to be taken as prescribed.
- Patient Preference in Terms of Overall Preference and Preference of Taste, Consistency, and Portability. [ Time Frame: 14 days ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00712543
|United States, New York|
|Arya Gastroenterology Associates|
|Brooklyn, New York, United States, 11237|
|United States, North Carolina|
|Wake Research Associates|
|Raleigh, North Carolina, United States, 27612|
|United States, Ohio|
|Rapid Medical Research|
|Cleveland, Ohio, United States, 44122|